Immune response in COVID-19: A review

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586

Changes of Intestinal Functions in Liver Cirrhosis

Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898

Untitled work

Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341

Structural basis of receptor recognition by SARS-CoV-2

Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,277

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

F. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,960

The COVID-19 vaccine development landscape

Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,954

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings

Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Mulangu, S., Dodd, L. E., Davey, R. T., Tshiani Mbaya, O., Proschan, M., Mukadi, D., Lusakibanza Manzo, M., Nzolo, D., Tshomba Oloma, A., Ibanda, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910993 · Cited by 1,605

COVID-19 infection: the perspectives on immune responses

Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., Bucci, E., Piacentini, M., Ippolito, G., & Melino, G. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0530-3 · Cited by 1,594

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537

Prognostic impact of disease-related malnutrition

Norman, K., Pichard, C., Lochs, H., & Pirlich, M. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2007.10.007 · Cited by 1,507

Adult haemophagocytic syndrome

Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M. A., & Bosch, X. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61048-x · Cited by 1,442

Potential interventions for novel coronavirus in China: A systematic review

Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

FURUTA, Y., KOMENO, T., & NAKAMURA, T. (2017) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.93.027 · Cited by 1,070

Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China

Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K. D., Convalescent Plasma Study Group, Nguyen-Van-Tam, J. S., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 983

Use of convalescent plasma therapy in SARS patients in Hong Kong

Cheng, Y., Wong, R., Soo, Y. O. Y., Wong, W. S., Lee, C. K., Ng, M. H. L., Chan, P., Wong, K. C., Leung, C. B., & Cheng, G. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1271-9 · Cited by 958

Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial

Schuetz, P., Fehr, R., Baechli, V., Geiser, M., Deiss, M., Gomes, F., Kutz, A., Tribolet, P., Bregenzer, T., Braun, N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32776-4 · Cited by 910 · cited 1×

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 847

Pathogenesis of COVID-19 from a cell biology perspective

Mason, R. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.00607-2020 · Cited by 841

Oral oseltamivir treatment of influenza in children

WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697

Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

Hung, I. F., To, K. K., Lee, C.-K., Lee, K.-L., Chan, K., Yan, W.-W., Liu, R., Watt, C.-L., Chan, W.-M., Lai, K.-Y., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq106 · Cited by 678

COVID-19: Immunology and treatment options

Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 669

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., & Nabel, G. J. (2004) · Nature · doi:10.1038/nature02463 · Cited by 665

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses

Siegel, D., Hui, H. C., Doerffler, E., Clarke, M. O., Chun, K., Zhang, L., Neville, S., Carra, E., Lew, W., Ross, B., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01594 · Cited by 643

The immune system

Nicholson, L. B. (2016) · Essays in Biochemistry · doi:10.1042/ebc20160017 · Cited by 623

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608

An Update on Current Therapeutic Drugs Treating COVID-19

Wu, R., Wang, L., Kuo, H.-C. D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 599

Candidate drugs against SARS-CoV-2 and COVID-19

McKee, D. L., Sternberg, A., Stange, U., Laufer, S., & Naujokat, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104859 · Cited by 562

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

van Griensven, J., Edwards, T., de Lamballerie, X., Semple, M. G., Gallian, P., Baize, S., Horby, P. W., Raoul, H., Magassouba, N., Antierens, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1511812 · Cited by 536

Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study

Deng, L., Li, C., Zeng, Q., Liu, X., Li, X., Zhang, H., Hong, Z., & Xia, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.002 · Cited by 505

Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries

Kwok, K. O., Lai, F., Wei, W. I., Wong, S. Y. S., & Tang, J. W. T. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.027 · Cited by 499

Convalescent plasma in Covid-19: Possible mechanisms of action

Rojas, M., Rodríguez, Y., Monsalve, D. M., Acosta-Ampudia, Y., Camacho, B., Gallo, J. E., Rojas-Villarraga, A., Ramírez-Santana, C., Díaz-Coronado, J. C., Manrique, R., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102554 · Cited by 491

Basic Immunology: Functions and Disorders of the Immune System

Dorak, M. T. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.2.185-a · Cited by 486

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Sissoko, D., Laouenan, C., Folkesson, E., M’Lebing, A.-B., Beavogui, A.-H., Baize, S., Camara, A.-M., Maes, P., Shepherd, S., Danel, C., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001967 · Cited by 478

Nutrients and their role in host resistance to infection

Field, C. J., Johnson, I. R., & Schley, P. D. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.16 · Cited by 431

Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Zhang, B., Liu, S., Tan, T., Huang, W., Dong, Y., Chen, L., Chen, Q., Zhang, L., Zhong, Q., Zhang, X., et al. (2020) · Chest · doi:10.1016/j.chest.2020.03.039 · Cited by 420

The Emperor of All Maladies: A Biography of Cancer

Mukherjee, S. (2010) · Cited by 416

Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion

Boriskin, Y., Leneva, I., Pecheur, E.-I., & Polyak, S. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784049658 · Cited by 410

Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China

Ye, M., Fu, D., Ren, Y., Wang, F., Wang, D., Zhang, F., Xia, X., & Lv, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25882 · Cited by 410

Coronavirus Disease 2019 (COVID‐19)

(2020) · Journal of Midwifery & Women's Health · doi:10.1111/jmwh.13196 · Cited by 391

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients

Soo, Y. O. Y., Cheng, Y., Wong, R., Hui, D. S., Lee, C. K., Tsang, K. K. S., Ng, M. H. L., Chan, P., Cheng, G., & Sung, J. J. Y. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00956.x · Cited by 381

Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea

Ahn, J. Y., Sohn, Y., Lee, S. H., Cho, Y., Hyun, J. H., Baek, Y. J., Jeong, S. J., Kim, J. H., Ku, N. S., Yeom, J.-S., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e149 · Cited by 352

Zinc and immunity: An essential interrelation

Maares, M., & Haase, H. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.03.022 · Cited by 346

Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience

Ko, J.-H., Seok, H., Cho, S. Y., Ha, Y. E., Baek, J. Y., Kim, S. H., Kim, Y.-J., Park, J. K., Chung, C. R., Kang, E.-S., et al. (2018) · Antiviral Therapy · doi:10.3851/imp3243 · Cited by 323

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis

Karakike, E., & Giamarellos-Bourboulis, E. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00055 · Cited by 304

Oseltamivir: A Review of its Use in Influenza

McClellan, K., & Perry, C. M. (2001) · Drugs · doi:10.2165/00003495-200161020-00011 · Cited by 257

Assessing the human immune system through blood transcriptomics

Chaussabel, D., Pascual, V., & Banchereau, J. (2010) · BMC Biology · doi:10.1186/1741-7007-8-84 · Cited by 252

Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital

Yeh, K.-M., Chiueh, T.-S., Siu, L. K., Lin, J.-C., Chan, P. K. S., Peng, M.-Y., Wan, H.-L., Chen, J.-H., Hu, B.-S., Perng, C.-L., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki346 · Cited by 247

The Emperor of all Maladies: A Biography of Cancer

Huilgol, N. (2011) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.80439 · Cited by 239

Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome

Tang, N. L.-S., Chan, P. K.-S., Wong, C.-K., To, K.-F., Wu, A. K.-L., Sung, Y.-M., Hui, D. S.-C., Sung, J. J.-Y., & Lam, C. W.-K. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.054460 · Cited by 232

Basic Immunology : Functions and Disorders of the Immune System

Abbas, A. K., & Lichtman, A. H. (2001) · Cited by 228

Antimalarial drugs in the treatment of rheumatological diseases.

Rynes, R. I. (1997) · Rheumatology · doi:10.1093/rheumatology/36.7.799 · Cited by 167

Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry

Wessling‐Resnick, M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051749 · Cited by 166

Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China

Yu, H., Gao, Z., Feng, Z., Shu, Y., Xiang, N., Zhou, L., Yang, H., Feng, S., Peng, Z., Li, Z., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002985 · Cited by 148

Treatment of severe acute respiratory syndrome with convalescent plasma.

Wong, V. W., Dai, D., Wu, A. K. L., & Sung, J. J. �. (2003) · PubMed · Cited by 142

Immunomodulatory properties of milk

Cross, M. L., & Gill, H. S. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500002294 · Cited by 122

Antiviral activities of whey proteins

Ng, T. B., Cheung, R. C. F., Wong, J. H., Wang, Y., Ip, D. T.-M., Wan, D. C., & Xia, J. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6818-4 · Cited by 95

Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection

Kumar, S., Nyodu, R., Maurya, V. K., & Saxena, S. K. (2020) · Medical virology · doi:10.1007/978-981-15-4814-7_5 · Cited by 91

Successful treatment of avian influenza with convalescent plasma.

Kong, L.-B., & Zhou, B. P. (2006) · PubMed · Cited by 73

Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation

Hancock, A. S., Stairiker, C. J., Boesteanu, A. C., Monzón‐Casanova, E., Łukasiak, S., Mueller, Y. M., Stubbs, A., García‐Sastre, A., Turner, M., & Katsikis, P. D. (2018) · Journal of Virology · doi:10.1128/jvi.01325-18 · Cited by 58

Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial

Hirota, M., Shimosegawa, T., Kitamura, K., Takeda, K., Takeyama, Y., Mayumi, T., Ito, T., Takenaka, M., Iwasaki, E., Sawano, H., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01644-z · Cited by 52

Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease

Sai, J. K., Suyama, M., Kubokawa, Y., Matsumura, Y., Inami, K., & Watanabe, S. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0148-1 · Cited by 41

Characterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2Preprint

Ni, L., Ye, F., Chen, M., Yu, F., Deng, Y., Zhao, H. J., Peng, W., Ge, J., Li, X., Sun, L., et al. (2020) · medRxiv · doi:10.1101/2020.03.17.20036640 · Cited by 40

Advances in clinical diagnosis and treatment of severe acute respiratory syndrome

Nie, Q. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i6.1139 · Cited by 38

Medication for COVID-19—an Overview of Approaches Currently Under Study

Stahlmann, R., & Lode, H. M. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0213 · Cited by 38

The starting line for COVID-19 vaccine development

Lee, N. L. S., & McGeer, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31239-3 · Cited by 25

Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: A systematic review and meta‐analysis

Vlieg‐ Boerstra, B., de Jong, N., Meyer, R., Agostoni, C., De Cosmi, V., Grimshaw, K., Milani, G. P., Muraro, A., Oude Elberink, H., Pali‐ Schöll, I., et al. (2022) · Allergy · doi:10.1111/all.15136 · Cited by 75

Exposure to Perfluoroalkyl Substances and Mortality for COVID-19: A Spatial Ecological Analysis in the Veneto Region (Italy)

Catelan, D., Biggeri, A., Russo, F., Gregori, D., Pitter, G., Da Re, F., Fletcher, T., & Canova, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052734 · Cited by 47